🦊/Investors

Esplanade Ventures

Venture capital

Toronto · Pre-Seed–Series B · 11 people tracked

Find your way into Esplanade Ventures

610 people in our graph share verified history with the Esplanade Ventures team — schools, employers, funds. One of them is your warm intro.

Paul Veradittakitunlockedknows Alexandre Nossovskoi · together at Creative Destruction Lab (overlapped)
×4knows the team · via Massachusetts Institute of Technology
×5knows the team · via Creative Destruction Lab
knows the team · via Western University
knows the team · via iGan Partners
Fox Verdict
Sign up to see your fit

Investment thesis

The firm targets bold ideas in digital health that leverage AI and technology to redefine healthcare access, efficiency, and outcomes. Investment focus is on software-enabled solutions directly impacting patients or healthcare professionals, explicitly excluding invasive devices and traditional biotech. The firm leverages its team's collective 100+ years of healthcare operating and investing experience to support portfolio companies with commercialization expertise in North America.

Source: firm website, verified Aug 7, 2026.

Stage
Pre-Seed–Series B
HQ
Toronto, QC, CA
Leads rounds
Leads
Instruments
Equity
Founded
2019
Last 12 months
1 investment
AUM
$17M
Tracked investments
10

Team · 11 people

from the firm's website & public directories
Dr. Sheldon Elman· Co-Founder & Chairman

Physician and co-founder serving as Chairman, with over 45 years of experience in healthcare.

Stuart M. Elman· Co-Founder

Co-founder with over 20 years of experience in healthcare.

Alexandre Nossovskoi· Principalin

Principal with over 10 years of experience across venture capital, innovation, and healthcare.

Josh Blair· Venture Partner

Venture Partner with over 15 years of experience in healthtech.

Dr. Yosef Berlyand· Advisor

Physician and Advisor with over 12 years of experience in healthcare.

Kavuchaljan Ganesathasan· VP Finance

VP Finance with over 6 years of experience in healthcare and public accounting.

Simon Kennedy· Senior Advisor

Senior Advisor with over 36 years in public service and policy, including 6+ years in healthcare.

What they invest in

from 9 of 10 portfolio companies

Healthtech ×6Digital Health ×5Medical Devices ×4AI & Machine Learning ×3FemTech ×2Biotech ×1Consumer ×1Future of Work ×1

HQs:United States×6

Investments · 10 tracked

founders shown can be your intro path

By year:2025 · 22021 · 32020 · 22019 · 18 dated

Bonehealthtechbonehealthtech.comin𝕏✓ verified

Osteoboost is an FDA-cleared bone health solution designed for postmenopausal women with osteopenia.

BiotechFemTechHealthtechLongevityMedical DevicesRedwood City, US

Dr. Dan Burnett(Founder & CEO of Theranova and Osteoboost Co-Founder)Dr. Shane Mangrum(PM&R Physician and Osteoboost Co-Founder)Laura Yecies(Chief Executive Officer & President)in

BoardMichael Jaasma(Chief Scientific Officer and Osteoboost Co-Founder)inJohn Osborne(Director)

Co-investorsAmbit Health VenturesBand of AngelsHouston Angel NetworkIT-Farm CorporationPortfoliaReno Seed Fund+1 more

Osteoboostosteoboost.comin𝕏✓ verified

Osteoboost is an FDA-cleared, drug-free prescription device that uses precision vibration therapy to slow bone density and strength loss in postmenopausal women with osteopenia.

Digital HealthFemTechMedical Devices

Dan Burnett(Co-Founder)inMichael Jaasma(Chief Scientific Officer and Co-Founder)inShane Mangrum(Co-Founder)inLaura Yecies(Chief Executive Officer & President)inPamela M. Peeke(Chief Medical Officer)in

Co-investorsAmbit Health VenturesBand of AngelsGolden SeedsGood Growth CapitalHealthtech CapitalNew York Angels+3 more

AHAgoaha.ioin𝕏Sep 2025 · $11.4M

AHA is a chat-based tool from TheVentureCity that gives founders feedback on their startup pitch and fundraising strategy, drawing on questions investors ask and industry insights.

AI & Machine LearningFuture of WorkSaaS

Co-investorsTheVentureCityah! VenturesCorrelation VenturesKoch Disruptive TechnologiesNorwest Venture PartnersPear VC

Cerula Carecerulacare.cominFeb 2025 · $3.7M

HealthtechWest Hartford, US

Supriya Laknidhi(Executive Officer, Director)inKyle Lavin(Executive Officer, Director)in

BoardElla Seitz(Director)in

Co-investorsAmplify CapitalDigiTx Partners LLCFlare Capital PartnersSpringTime Ventures

Cleerlycleerly.comin𝕏Series B · Jun 2021 · $43M

Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.

AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US

James Min, MD(Founder)inJames K. Min(Executive Officer, Director)in

BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)inLouis Samson(Director)

Co-investorsBattery VenturesBreyer CapitalDigiTx Partners LLCInsight PartnersLRVHealthNew Leaf Venture Partners+4 more

Embr Labsembrlabs.comDec 2020

Embr Labs makes the Embr Wave, a wrist-worn thermal wearable that delivers heating and cooling sensations to the skin at the press of a button to help users feel more comfortable with temperature.

ConsumerHardwareWellness & FitnessBoston, US

Samuel Shames(Executive Officer)David Cohen-Tanugi(Executive Officer, Director)Matthew J. Smith(Executive Officer, Director)inMichael Gibson(Executive Officer, Director)Elizabeth Gazda(Executive Officer, Director)in

BoardWilliam Schroeder(Director)

Co-investorsJoyance PartnersSafar PartnersSocial Starts

Igentifyigentify.cominSep 2019 · $11M

iGentify provides a platform combining patient engagement and clinical data management for healthcare providers.

AI & Machine LearningDigital HealthHealthtech

Co-investorsLIP Ventures BoutiqueWorld Trade Ventures (WTV)aMoonOurCrowd

Sana Healthsana.ioinApr 2021 · $13M

Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind.

Digital HealthHealthtechMedical DevicesMental HealthLafayette, US

Richard Hanbury(Founder)in

Co-investorsCheckmate Capital Group LLCClick VenturesFlucas VenturesHarmonix FundHealthtech CapitalMarram Ventures+5 more

Wellthwellthapp.comin𝕏Series A · May 2020 · $10M

Wellth helps individuals with chronic diseases develop positive behavioral habits that improve health outcomes and quality of life.

Digital HealthHealthtech

Matthew Loper(CEO)in

Co-investorsComcast VenturesDistributed VenturesFCA Venture PartnersMercato PartnersNew York Life VenturesPortfolia+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Bone Health Technologies

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Esplanade Ventures made?
Esplanade Ventures has 10 tracked investments, including 2 dated in the last 24 months.
What stage does Esplanade Ventures invest at?
Esplanade Ventures invests at the Pre-Seed, Seed, Series A, Series B stages.
What sectors does Esplanade Ventures focus on?
Esplanade Ventures focuses on AI & Machine Learning, Biotech, Digital Health, Enterprise Software, Healthtech, Medical Devices, SaaS.
Where is Esplanade Ventures located?
Esplanade Ventures is headquartered in Toronto, CA.
Does Esplanade Ventures lead rounds?
Yes, Esplanade Ventures leads investment rounds.

Co-investors · 6

Vensana Capital

Vensana Capital is a venture capital and growth equity investment firm focused on partnering with entrepreneurs building breakthrough medical technology innovations to transform healthcare.

Both backed · 1
Distributed Ventures

Distributed Ventures is an early-stage venture firm that leads Seed and Series A investments in companies innovating across the health, insurance, and wealth risk ecosystems.

Both backed · 1
$1M – $5M
Harmonix Fund

Harmonix is an early-stage venture capital firm focused on advancing human health and quality of life by backing entrepreneurs and companies in healthcare, life sciences, and deep tech.

Both backed · 1
Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund, established in 2010, invests in biotechnology companies developing therapeutics in immuno-oncology, regenerative medicine, and gene therapy, including platform technologies and novel vaccines. The fund targets early-stage companies addressing unmet medical needs through translational research and scientific innovation.

$16.2M
quadraScope Venture Fund

quadraScope invests in healthcare companies developing pharmaceuticals, diagnostics, software, equipment and devices that address the biological hallmarks of aging through biological age reversal and longevity research.

Vistara Growth

Vistara Growth is a technology-focused financing firm that partners with growth-stage companies, providing capital as both a lender and an equity partner.

Firms observed investing alongside Esplanade Ventures, from public investor directories. Shared companies are the overlap with Esplanade Ventures's recorded portfolio.

Similar investors

Featured in lists